HER2 Inhibitor

Puma drug better than Herceptin in HER2 breast cancers -trial
Reuters
Mon, 04/7/14 - 10:33 am
Herceptin
Puma Biotechnology
HER2 Inhibitor
breast cancer
neratinib
Array BioPharma Licenses Cancer Drug ARRY-543 to ASLAN Pharmaceuticals
Marketwatch
Wed, 07/13/11 - 11:55 am
Array Biopharma
ARRY-543
Aslan
HER2 Inhibitor
cancer
Drug combo helps women with early breast cancer
Yahoo/AP
Sat, 12/11/10 - 12:00 pm
Tykerb
Herceptin
HER2 Inhibitor
breast cancer
Genentech
GSK
ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer
Yahoo/BusinessWire
Sat, 12/11/10 - 11:48 am
Immunogen
T-DM1
Pertuzumab
breast cancer
HER2 Inhibitor
trastuzumab
Array BioPharma Announces Positive Results for HER2 Inhibitor, ARRY-380, in Breast Cancer Patients
Yahoo/BusinessWire
Sat, 10/2/10 - 11:20 am
Array Biopharma
breast cancer
ARRY-380
HER2 Inhibitor